Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:GEVO NYSEAMERICAN:KULR NASDAQ:LUCD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$1.95-6.7%$2.42$1.93▼$20.00$15.13M-0.461.08 million shs117,594 shsGEVOGevo$1.96-4.9%$1.65$0.92▼$3.39$474.01M2.185.08 million shs5.02 million shsKULRKULR Technology Group$4.22-0.7%$5.05$2.16▼$43.92$173.48M2.12.14 million shs964,414 shsLUCDLucid Diagnostics$1.03$1.09$0.75▼$1.80$137.48M1.241.05 million shs533,449 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%-5.26%-4.17%-15.85%-86.76%GEVOGevo0.00%+1.98%+19.08%+56.06%+20.47%KULRKULR Technology Group0.00%-11.46%-9.57%-40.39%+89.73%LUCDLucid Diagnostics0.00%-5.50%-18.25%-10.43%+31.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$1.95-6.7%$2.42$1.93▼$20.00$15.13M-0.461.08 million shs117,594 shsGEVOGevo$1.96-4.9%$1.65$0.92▼$3.39$474.01M2.185.08 million shs5.02 million shsKULRKULR Technology Group$4.22-0.7%$5.05$2.16▼$43.92$173.48M2.12.14 million shs964,414 shsLUCDLucid Diagnostics$1.03$1.09$0.75▼$1.80$137.48M1.241.05 million shs533,449 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%-5.26%-4.17%-15.85%-86.76%GEVOGevo0.00%+1.98%+19.08%+56.06%+20.47%KULRKULR Technology Group0.00%-11.46%-9.57%-40.39%+89.73%LUCDLucid Diagnostics0.00%-5.50%-18.25%-10.43%+31.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.50Moderate Buy$22.831,070.94% UpsideGEVOGevo 2.33Hold$8.13314.54% UpsideKULRKULR Technology Group 3.00Buy$40.00847.87% UpsideLUCDLucid Diagnostics 3.00Buy$3.65254.37% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, LUCD, KULR, and GEVO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/17/2025GEVOGevoUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$1.15 ➝ $2.259/5/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$2.00 ➝ $2.508/13/2025GEVOGevoZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.008/12/2025ALURAllurion TechnologiesZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/16/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.00(Data available from 9/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$32.11M0.47N/AN/A($30.08) per share-0.06GEVOGevo$16.92M28.01N/AN/A$2.04 per share0.96KULRKULR Technology Group$10.74M16.15N/AN/A$1.68 per share2.51LUCDLucid Diagnostics$4.35M31.61N/AN/A($0.78) per share-1.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$7.20M-$12.53N/AN/AN/A-158.30%N/A-59.91%11/12/2025 (Estimated)GEVOGevo-$78.64M-$0.26N/AN/AN/A-72.76%-12.04%-9.09%11/6/2025 (Estimated)KULRKULR Technology Group-$17.52M-$0.12N/AN/AN/A-133.21%-29.89%-27.79%11/12/2025 (Estimated)LUCDLucid Diagnostics-$45.53M-$1.19N/AN/AN/A-1,476.35%N/A-120.43%11/12/2025 (Estimated)Latest ALUR, LUCD, KULR, and GEVO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025ALURAllurion Technologies-$0.65-$0.57+$0.08-$1.28$6.20 million$3.38 million8/11/2025Q2 2025GEVOGevo-$0.06$0.01+$0.07$0.01$43.69 million$43.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AKULRKULR Technology GroupN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.021.70GEVOGevo0.292.332.10KULRKULR Technology GroupN/A8.298.09LUCDLucid DiagnosticsN/A1.151.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%GEVOGevo35.17%KULRKULR Technology Group21.23%LUCDLucid Diagnostics74.01%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies9.60%GEVOGevo4.00%KULRKULR Technology Group11.21%LUCDLucid Diagnostics6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.76 million7.02 millionOptionableGEVOGevo100241.84 million232.17 millionOptionableKULRKULR Technology Group6041.11 million36.50 millionNot OptionableLUCDLucid Diagnostics70133.48 million124.40 millionNo DataALUR, LUCD, KULR, and GEVO HeadlinesRecent News About These CompaniesLucid Diagnostics: Holding Onto Medicare Coverage HopesSeptember 29 at 5:29 AM | seekingalpha.comLucid Diagnostics (NASDAQ:LUCD) Raised to Hold at Wall Street ZenSeptember 29 at 2:15 AM | americanbankingnews.comLucid Diagnostics (NASDAQ:LUCD) Rating Increased to Hold at Wall Street ZenSeptember 28 at 3:48 AM | marketbeat.comLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of DirectorsSeptember 25, 2025 | prnewswire.comLucid Diagnostics (NASDAQ:LUCD) Cut to Sell at Wall Street ZenSeptember 20, 2025 | marketbeat.comLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsSeptember 16, 2025 | prnewswire.comLucid Diagnostics Announces Public Stock OfferingSeptember 12, 2025 | msn.comLucid Diagnostics Completes Public Offering for $26.9 MillionSeptember 11, 2025 | tipranks.comLucid Diagnostics Announces Closing of Public Offering of Common StockSeptember 11, 2025 | prnewswire.comLucid Prices Public Share OfferingSeptember 11, 2025 | baystreet.caLucid Diagnostics Announces Pricing of Public Offering of Common StockSeptember 10, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockSeptember 9, 2025 | prnewswire.comLucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)September 8, 2025 | seekingalpha.comAlyeska Investment Group L.P. Invests $2.81 Million in Lucid Diagnostics Inc. $LUCDSeptember 8, 2025 | marketbeat.comLucid Diagnostics price target raised to $2.50 from $2 at BTIGSeptember 5, 2025 | msn.comLucid Diagnostics to Host Investor Call on Monday, September 8, 2025September 5, 2025 | prnewswire.comGhisallo Capital Management LLC Takes $629,000 Position in Lucid Diagnostics Inc. $LUCDSeptember 2, 2025 | marketbeat.comCanaccord Genuity Remains a Buy on Lucid Diagnostics (LUCD)August 29, 2025 | theglobeandmail.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27, 2025 | prnewswire.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comInsider Buying: Lucid Diagnostics (NASDAQ:LUCD) Director Acquires 100,000 Shares of StockAugust 23, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, LUCD, KULR, and GEVO Company DescriptionsAllurion Technologies NYSE:ALUR$1.95 -0.14 (-6.70%) Closing price 03:58 PM EasternExtended Trading$2.06 +0.11 (+5.64%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Gevo NASDAQ:GEVO$1.96 -0.10 (-4.85%) Closing price 04:00 PM EasternExtended Trading$1.98 +0.03 (+1.28%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.KULR Technology Group NYSEAMERICAN:KULR$4.22 -0.03 (-0.71%) Closing price 04:10 PM EasternExtended Trading$4.23 +0.01 (+0.24%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, develops and commercializes thermal management technologies for electronics, batteries, and other components applications in the United States. It provides lithium-ion battery thermal runaway shields; automated battery cell screening and test systems; cellchecks; safecases; fiber thermal interface materials; phase change material heat sinks; internal short circuit devices; and CRUX cathodes. The company's technologies are used in electric vehicles, energy storage, battery recycling transportation, cloud computing, and 5G communication devices. It sells its products for applications, such as lithium-ion battery energy storage, electric vehicles, 5G communication, cloud computer infrastructure, consumer, and industrial devices. The company was formerly known as KT High-Tech Marketing Inc. and changed its name to KULR Technology Group, Inc. in August 2018. KULR Technology Group, Inc. was founded in 2013 and is based in San Diego, California.Lucid Diagnostics NASDAQ:LUCD$1.03 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.03 0.00 (0.00%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? MarketBeat Week in Review – 09/22 - 09/26 Get Exposure to Millennials' Purchasing Power With This ETF Beam Global Gets Buy Rating With 101% Upside Potential Institutional Buying Sets a High Floor for Microsoft Stock High-Momentum ETFs to Mine for Gold, Silver, and Bitcoin ASML Is a Hidden Gem in This Technology Rally, a Catch Up Play Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
